Inhibition of FABP4 attenuates hyperoxia-induced lung injury and fibrosis via inhibiting TGF-β signaling in neonatal rats

Medicine and Dentistry

• Pulmonary Fibrosis 100%
• Hyperoxia-Induced Lung Injury 100%
• Fatty Acid Binding Protein 4 100%
• Hyperoxia 66%
• Lung Dysplasia 50%
• Phosphate Buffered Saline 50%
• Neonatal Infant 33%
• Drug Megadose 33%
• Low Drug Dose 33%
• Injury 16%
• Fibrosis 16%
• Prematurity 16%
• Placebo 16%
• Oxygen Therapy 16%
• Nonoxinol 9 16%
• Chronic Lung Disease 16%
• Intraperitoneal Drug Administration 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Fibrosis 100%
• Hyperoxia-Induced Lung Injury 100%
• Fatty Acid Binding Protein 4 100%
• Phosphate Buffered Saline 50%
• Lung Dysplasia 50%
• Placebo 16%
• Injury 16%
• Prematurity 16%
• Intraperitoneal Injection 16%
• Chronic Lung Disease 16%
• Nonoxynol-9 16%
• Fibrosis 16%